Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) Sees Significant Drop in Short Interest

Ono Pharmaceutical Co., Ltd. (OTCMKTS:OPHLF) was the recipient of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 5,959,200 shares, a decrease of 17.4% from the October 31st total of 7,214,300 shares. Based on an average trading volume of 3,800 shares, the days-to-cover ratio is presently 1,568.2 days.

Ono Pharmaceutical Stock Performance

Ono Pharmaceutical stock opened at $11.35 on Monday. Ono Pharmaceutical has a one year low of $10.26 and a one year high of $19.09. The company has a market cap of $5.84 billion, a P/E ratio of 8.47 and a beta of 0.58. The business has a fifty day moving average of $12.93 and a two-hundred day moving average of $13.68.

Ono Pharmaceutical Company Profile

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.